# Trial Of AG-013736, Cisplatin, And Gemcitabine For Patients With Squamous Non-Small Cell Lung Cancer

> **NCT00735904** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 38 (actual)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung (NSCLC)

## Interventions

- **DRUG:** AG-013736
- **DRUG:** gemcitabine
- **DRUG:** cisplatin

## Key facts

- **NCT ID:** NCT00735904
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2013-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00735904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00735904, "Trial Of AG-013736, Cisplatin, And Gemcitabine For Patients With Squamous Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00735904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*